Statins × cardiovascular events

TrialThe New England journal of medicine1998

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study GroupPubMed ↗Publisher ↗

What the trial testedas reported · 9,014 people · 1998

No range given

Reported lower cardiovascular events, no range given

−29.0percentage points

As reported

difference −29.0 percent, no interval

One number in the abstract

the abstract, start to end

infarction (reduction in risk, 29 percent; P<0.001), death from

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Cardiovascular events
−29.0
StatinsCardiovascular events
1 / 3

1,010 papers cite itlatest 60 shown

1998
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

4 trials

Full record →Abstract, authors, funding and every citing paper · PMID 9841303